Mechanisms of T Cell Tolerance and Suppression in Cancer Mediated by Tumor-Associated Antigens and Hormones

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|1|3-14

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.1, 2007-02, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 41-53

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1133-1138

Bentham Science Publishers

Access to resources Recommend Favorite

The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion

By  

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 404-413

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Tumor Cell Necrosis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 1, 2010-01 ,pp. : 56-68

Bentham Science Publishers

Access to resources Recommend Favorite